Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11939902
[patent_doc_number] => 20170244051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'Benzimidazo[1,2-a]Benzimidazole Derivatives for Electronic Applications'
[patent_app_type] => utility
[patent_app_number] => 15/453591
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19392
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453591
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453591 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | Mar 7, 2017 | Issued |
Array
(
[id] => 13856167
[patent_doc_number] => 10189792
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Method and apparatus for synthesizing a water-soluble hexaaryl biimidazole
[patent_app_type] => utility
[patent_app_number] => 15/453519
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 1184
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453519
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453519 | Method and apparatus for synthesizing a water-soluble hexaaryl biimidazole | Mar 7, 2017 | Issued |
Array
(
[id] => 14102161
[patent_doc_number] => 20190092756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => CRYSTALLINE FORM A OF 2-[(2R)-2-METHYL-2-PYRROLIDYL]-1H-BENZIMIDAZOLE-7-CARBOXAMIDE DIHYDROCHLORIDE AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/082830
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082830
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082830 | CRYSTALLINE FORM A OF 2-[(2R)-2-METHYL-2-PYRROLIDYL]-1H-BENZIMIDAZOLE-7-CARBOXAMIDE DIHYDROCHLORIDE AND PREPARATION METHOD THEREOF | Mar 7, 2017 | Abandoned |
Array
(
[id] => 11949466
[patent_doc_number] => 20170253617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Substituted 5-Membered Heterocyclic Analogs as Protease Activated Receptor 4 (PAR-4) Antagonists'
[patent_app_type] => utility
[patent_app_number] => 15/452686
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19522
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15452686
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/452686 | Substituted 5-membered heterocyclic analogs as protease activated receptor 4 (PAR-4) antagonists | Mar 6, 2017 | Issued |
Array
(
[id] => 11949421
[patent_doc_number] => 20170253569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'THIAZOLIDINONE COMPOUNDS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/449406
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 138678
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449406
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449406 | Thiazolidinone compounds and use thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 13196053
[patent_doc_number] => 10112936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Five-membered heterocycles useful as serine protease inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/440346
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55049
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440346
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440346 | Five-membered heterocycles useful as serine protease inhibitors | Feb 22, 2017 | Issued |
Array
(
[id] => 13746629
[patent_doc_number] => 10166239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-01
[patent_title] => Tropomyosin-related kinase (Trk) inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/436195
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32192
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 385
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436195
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/436195 | Tropomyosin-related kinase (Trk) inhibitors | Feb 16, 2017 | Issued |
Array
(
[id] => 16549726
[patent_doc_number] => 10882875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Process for the preparation of a triaryl phosphate ester composition
[patent_app_type] => utility
[patent_app_number] => 15/999341
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4904
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999341
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999341 | Process for the preparation of a triaryl phosphate ester composition | Feb 12, 2017 | Issued |
Array
(
[id] => 12489774
[patent_doc_number] => 09994535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Desferrithiocin polyether analogues
[patent_app_type] => utility
[patent_app_number] => 15/428232
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7711
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428232 | Desferrithiocin polyether analogues | Feb 8, 2017 | Issued |
Array
(
[id] => 11954746
[patent_doc_number] => 20170258897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'ANTI-VIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/419784
[patent_app_country] => US
[patent_app_date] => 2017-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19146
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15419784
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/419784 | Anti-viral compounds | Jan 29, 2017 | Issued |
Array
(
[id] => 12098174
[patent_doc_number] => 09855257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => '4-alkynyl imidazole derivative and medicine comprising same as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 15/414200
[patent_app_country] => US
[patent_app_date] => 2017-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30703
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15414200
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/414200 | 4-alkynyl imidazole derivative and medicine comprising same as active ingredient | Jan 23, 2017 | Issued |
Array
(
[id] => 13777773
[patent_doc_number] => 20190002425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => C-Glucoside Derivative Containing Fused Phenyl Ring or Pharmaceutically Acceptable Salt Thereof, Process for Preparing Same, and Pharmaceutical Composition Comprising Same
[patent_app_type] => utility
[patent_app_number] => 16/067707
[patent_app_country] => US
[patent_app_date] => 2017-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067707
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067707 | C-glucoside derivative containing fused phenyl ring or pharmaceutically acceptable salt thereof, process for preparing same, and pharmaceutical composition comprising same | Jan 2, 2017 | Issued |
Array
(
[id] => 11568567
[patent_doc_number] => 20170107211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'NOVEL BENZIMIDAZOLE COMPOUND AND MEDICAL USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/395338
[patent_app_country] => US
[patent_app_date] => 2016-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37654
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15395338
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/395338 | Benzimidazole compounds and medical uses thereof | Dec 29, 2016 | Issued |
Array
(
[id] => 16305277
[patent_doc_number] => 10774055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Process for preparing 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide
[patent_app_type] => utility
[patent_app_number] => 16/066965
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4330
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066965
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/066965 | Process for preparing 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide | Dec 27, 2016 | Issued |
Array
(
[id] => 11742794
[patent_doc_number] => 20170196867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'INHIBITORS OF BETA-SECRETASE'
[patent_app_type] => utility
[patent_app_number] => 15/383287
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18158
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383287
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/383287 | Inhibitors of beta-secretase | Dec 18, 2016 | Issued |
Array
(
[id] => 11706156
[patent_doc_number] => 20170174653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'TLR7/8 ANTAGONISTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/381406
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 156326
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15381406
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/381406 | TLR7/8 antagonists and uses thereof | Dec 15, 2016 | Issued |
Array
(
[id] => 16483884
[patent_doc_number] => 20200377485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => HYDANTOIN MODULATORS OF KV3 CHANNELS
[patent_app_type] => utility
[patent_app_number] => 16/061557
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061557 | HYDANTOIN MODULATORS OF KV3 CHANNELS | Dec 15, 2016 | Abandoned |
Array
(
[id] => 12428124
[patent_doc_number] => 09975882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Heteroaromatic compounds as BTK inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/379745
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12838
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15379745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/379745 | Heteroaromatic compounds as BTK inhibitors | Dec 14, 2016 | Issued |
Array
(
[id] => 12428124
[patent_doc_number] => 09975882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Heteroaromatic compounds as BTK inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/379745
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12838
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15379745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/379745 | Heteroaromatic compounds as BTK inhibitors | Dec 14, 2016 | Issued |
Array
(
[id] => 12428124
[patent_doc_number] => 09975882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Heteroaromatic compounds as BTK inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/379745
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12838
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15379745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/379745 | Heteroaromatic compounds as BTK inhibitors | Dec 14, 2016 | Issued |